NASDAQ:RGC - Nasdaq - KYG7487R1002 - Common Stock - Currency: USD
449.55
+97.53 (+27.71%)
The current stock price of RGC is 449.55 USD. In the past month the price increased by 1460.94%. In the past year, price increased by 8873.05%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 54.29 | 708.16B | ||
JNJ | JOHNSON & JOHNSON | 15.29 | 369.72B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 19.6 | 302.74B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.51 | 221.76B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 18.8 | 216.78B | ||
MRK | MERCK & CO. INC. | 10.01 | 196.20B | ||
PFE | PFIZER INC | 7.33 | 133.39B | ||
SNY | SANOFI-ADR | 13.85 | 129.48B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.52 | 97.42B | ||
GSK | GSK PLC-SPON ADR | 6.99 | 77.70B | ||
ZTS | ZOETIS INC | 27.18 | 73.00B | ||
HLN | HALEON PLC-ADR | 22.49 | 49.69B |
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
REGENCELL BIOSCIENCE HOLDING
11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
Hong Kong 37918 HK
CEO: Yat-Gai Au
Employees: 12
Phone: 85221550823
The current stock price of RGC is 449.55 USD. The price increased by 27.71% in the last trading session.
The exchange symbol of REGENCELL BIOSCIENCE HOLDING is RGC and it is listed on the Nasdaq exchange.
RGC stock is listed on the Nasdaq exchange.
REGENCELL BIOSCIENCE HOLDING (RGC) has a market capitalization of 5.85B USD. This makes RGC a Mid Cap stock.
REGENCELL BIOSCIENCE HOLDING (RGC) currently has 12 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RGC does not pay a dividend.
REGENCELL BIOSCIENCE HOLDING (RGC) will report earnings on 2022-12-13, before the market open.
REGENCELL BIOSCIENCE HOLDING (RGC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.59).
The outstanding short interest for REGENCELL BIOSCIENCE HOLDING (RGC) is 2.37% of its float. Check the ownership tab for more information on the RGC short interest.
ChartMill assigns a technical rating of 9 / 10 to RGC. When comparing the yearly performance of all stocks, RGC is one of the better performing stocks in the market, outperforming 100% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to RGC. RGC has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months RGC reported a non-GAAP Earnings per Share(EPS) of -0.59. The EPS decreased by -321.43% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -58.95% | ||
ROE | -61.85% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 63% to RGC. The Buy consensus is the average rating of analysts ratings from 12 analysts.